ASTFX | ECLBX | ASTFX / ECLBX | |
Total Expense Ratio | 0.31 | 1.40 | 22% |
Annual Report Gross Expense Ratio | 0.32 | 1.58 | 20% |
Fund Existence | 16 years | 10 years | - |
Gain YTD | 0.403 | 0.851 | 47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.99B | 66.8M | 2,985% |
Annual Yield % from dividends | 2.80 | 2.09 | 134% |
Returns for 1 year | 1.17 | 2.60 | 45% |
Returns for 3 years | 1.68 | 6.58 | 26% |
Returns for 5 years | -2.75 | 1.53 | -179% |
Returns for 10 years | -0.12 | 8.76 | -1% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FEBZ | 34.76 | N/A | N/A |
TrueShares Structured OutcomeFebruaryETF | |||
JMUB | 49.41 | -0.07 | -0.14% |
JPMorgan Municipal ETF | |||
RAYE | 25.42 | -0.11 | -0.43% |
Rayliant Quantamental Emer Mkt Eq ETF | |||
IHE | 67.50 | -0.37 | -0.55% |
iShares US Pharmaceuticals ETF | |||
BITQ | 17.50 | -0.46 | -2.56% |
Bitwise Crypto Industry Innovators ETF |